Biopharmaceutical CDMO Service Market

Industry Size, Emerging Trends, Regions, Growth Insights, Opportunities, and Forecast By 2033

Biopharmaceutical CDMO Service Market by Type (Develop Innovative Drugs, Listed Patented Drug, Biosimilars, Others), by Application (Pharmaceutical Company, Biotechnology Company, Others), and by Region (North America, South America, Europe, Asia Pacific, MEA) – Global Share and Forecast to 2033

Region: Global | Format: Word, PPT, Excel | Report Status: Ongoing

According to the Market Statsville Group (MSG), the Global Biopharmaceutical CDMO Service Market size is expected to grow from USD 100.4 billion in 2023 to USD 192.2 billion by 2033, at a CAGR of 6.7% from 2023 to 2033. 

Biopharmaceutical contract development and manufacturing organization (CDMO) services offer a wide array of services, encompassing cell line development, process optimization, analytical testing, and regulatory compliance. Various CDMO organizations provide comprehensive support to biopharmaceutical companies, ranging from early-stage research and development (R&D) to large-scale commercial production. The biopharmaceutical CDMO offers advanced bioprocessing technologies, with efficient and scalable production of biologic drugs, such as monoclonal antibodies, vaccines, and gene therapies. The CDMOs focused on the client's requirements, offering flexibility in terms of production scale and customized solutions. 

The increasing complexity of biopharmaceutical products, including monoclonal antibodies, cell and gene therapies, and vaccines, demands specialized expertise and infrastructure, thereby driving the demand for the biopharmaceutical CDMO service market.  The surging demand for drug development and catering to the growing demand-supply chain on time create a lucrative demand for the market’s growth. The rise in personalized medicine and the need for smaller batch sizes to cater to niche patient populations further boosted the demand for the biopharmaceutical CDMO service market. The global pharmaceutical industry's focus on cost minimizing and risk mitigation led many companies to outsource drug development are factors that contribute to the market’s growth over the forecast period. 

Biopharmaceutical CDMO Service Market Segmental Analysis, 2023-2033

Based on type, the market is divided into develop innovative drugs, listed patented drug, biosimilars, and others. In 2023, the listed patented drug segment has emerged as dominant segment in the biopharmaceutical contract development and manufacturing organization (CDMO) service market, owing to increasing outsourcing of pharmaceutical companies developing and manufacturing patented drugs. CDMOs organizations offer process development, analytical testing, and commercial-scale production, for patented drugs, resulting in driving the market’s growth. In addition, the stringent regulatory requirements and quality standards for patented drugs have upsurged the demand for CDMO organizations. The pharmaceutical and biopharmaceutical companies contact CDMO organizations to maintain compliance and safety for the huge number of patented drugs, thereby fostering the market’s growth. 

Based on the regions, the global biopharmaceutical CDMO service market has been segmented across Europe, North America, Asia-Pacific, South America, and the Middle East & Africa. The increasing biopharmaceutical innovation and growing adoption of cutting-edge research and development in the region accelerated the market’s growth. The region's stringent regulatory compliance and standards create a lucrative growth opportunity for companies dealing in CDMO services, thereby augmenting the market’s growth. The COVID-19 pandemic further accelerated the demand for CDMO services to develop and produce vaccines and therapeutics to support rapid scale-up production and ensure the timely delivery of critical medicines, thus boosting the market’s growth. Further, the trend towards personalized medicine and the development of niche therapies require fueled biopharmaceutical CDMO service demand in the region.

Whereas Asia Pacific is expected to grow at the highest CAGR owing to the growing population and surging prevalence of chronic diseases. As more people in Asia Pacific gain access to healthcare services, there is a growing demand for innovative biopharmaceuticals which significantly increases the demand for the biopharmaceutical CDMO service market. Further, the region offers competitive labor costs and production capabilities, making it a preferable option for cost-effectiveness for outsourcing biopharmaceutical manufacturing, fueling the market’s growth over the forecast period. Also, small and medium enterprises (SMEs) can easily enter the market as the competitive rivalry in the market is witnessing high due to its growing demand for pharmaceuticals for any treatment irrespective of age and other discrimination. The increasing aging population, government initiatives to promote biopharmaceutical industries, growing disposable income, and increasing advancements in research activities and clinical trials are the factors that create a positive outlook for the market’s growth in the region. 

Biopharmaceutical CDMO Service Market Key Players, 2023

The Major key players in the global biopharmaceutical CDMO service market are: 

Recent Developments 

  • In October 2023, Advent International acquired Baxter International’s BioPharma Solutions (BPS) business. This acquisition will now be a standalone CDMO and will operate under the name Simtra BioPharma Solutions (Simtra). Simtra will offer the same solutions that were offered by the BPS.
  • In September 2023, KBI Biopharma, Inc. (KBI) launched SUREmAb, which offers safe, and cost-efficient monoclonal antibody (mAb) development and manufacturing. 
  • In November 2022, Global Healthcare Opportunities, or GHO Capital Partners LLP, and The Vistria Group, agreed to acquire Alcami Corporation, a pharmaceutical contract development and manufacturing organization (CDMO). This acquisition will strengthen their product offering and increase the global client reach.
  • In August 2022, Catalent, Inc. acquired Metrics Contract Services (Metrics), to strengthen its capabilities in integrated oral solid formulation development, manufacturing, and packaging.

Report Scope of the Global Biopharmaceutical CDMO Service Market 

This market research study categorizes the biopharmaceutical CDMO service market-based on type, and application area at the regional and global levels.

By Type Outlook (Sales, USD Million, 2019-2033)

  • Develop Innovative Drugs
  • Listed Patented Drug
  • Biosimilars
  • Others

By Application Outlook (Sales, USD Million, 2019-2033)

  • Pharmaceutical Company
  • Biotechnology Company
  • Others

By Region Outlook (Sales, USD Million, 2019-2033)

  • North America 
    • US
    • Canada
    • Mexico
  • Europe 
    • Germany
    • Italy
    • France
    • UK
    • Spain
    • Poland
    • Russia
    • The Netherlands
    • Norway
    • Czech Republic
    • Rest of Europe
  • Asia Pacific 
    • China
    • Japan
    • India
    • South Korea
    • Indonesia
    • Malaysia
    • Thailand
    • Singapore
    • Australia & New Zealand
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Northern Africa
    • Rest of MEA

Frequently Asked Questions

  • Key Issues Addressed
  • What is the market size and growth rate for different segmentations at a global, regional, & country level?
  • What is the customer buying behavior, key takeaways, and Porter's 5 forces of the market?
  • What are the key opportunities and trends for manufacturers involved in the supply chain?
  • What are the fundamental dynamics (drivers, restraints, opportunities, and challenges) of the market?
  • What and how regulations, schemes, patents, and policies are impacting the growth of the market?
  • How will existing companies adapt to the new change in technology?
  • The market player positioning, top winning strategies by years, company product developments, and launches will be?
  • How has COVID-19 impacted the demand and sales of in the market? Also, the expected BPS drop or rise count of the market and market predicted recovery period.
  • Who are the leading companies operating in the market? Also, who are the prominent startups that disrupt the market in coming years?
  • PUBLISHED ON: MARCH, 2024
  • BASE YEAR: 2023
  • FORECAST PERIOD: 2024-2033
  • STUDY PERIOD: 2019 - 2033
  • COMPANIES COVERED: 15
  • COUNTRIES COVERED: 24
  • NO OF PAGES: 281

Want to Review Complete Market Research Report

 
save 20%
$2450 $1950
 
save 25%
$4450 $3338
 
save 30%
$5850 $4095
 
save 35%
$8150 $5298

Budget constraints? Get in touch with us for special pricing

Request for Special Pricing

Customize this Report

  • Buy specific region or segment sections of this report
  • Buy specific region/country level reports
  • Request for Pricing Analysis, Market Dynamics, Recommendation & Conclusion
  • Companies Profiles based on Target Requirement
  • Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
  • Why Choose Market Statsville Group?
  • CXO’s Perspective
  • Real-Time Market AttractivenessIndex
  • Investment Pockets
  • Market Player Positioning
  • Competitive Heatmap
  • Parent &Peer Market Analysis
  • Primary Survey Analysis & Transcripts
  • Premium insights from industry experts
  • Robust Research Methodology
  • Market Trends & Opportunities
  • Market Growth Dynamics
  • Value/Supply Chain Analysis
  • Pre-&-Post Covid Market Scenario
  • Latest Technological Developments
  • Comprehensive Reports
  • 3-Rounds Quality Checks with Complete Assurance
  • Unlimited Post-Sales Support
  • Regular Report Updates
Didn't Get What you are looking for. Share your requirements here
Request for Customization

We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. I Accept